Marie Follo Selected Research

Anaphase-Promoting Complex-Cyclosome

1/2021	Targeting mitotic exit in solid tumors.
12/2013	BubR1 is frequently repressed in acute myeloid leukemia and its re-expression sensitizes cells to antimitotic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marie Follo Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 03/2006
7	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 05/2012
5	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2017
5	Leukemia 01/2021 - 04/2010
4	Multiple Myeloma 01/2021 - 09/2010
4	Lymphoma (Lymphomas) 12/2020 - 04/2010
4	Melanoma (Melanoma, Malignant) 11/2020 - 04/2012
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 12/2013
4	Inflammation (Inflammations) 09/2019 - 08/2010
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 09/2019
3	Epilepsy (Aura) 01/2021 - 01/2016
3	Neoplasm Metastasis (Metastasis) 01/2019 - 12/2010
2	Bone Marrow Failure Disorders 10/2022 - 01/2020
2	Adenocarcinoma 01/2021 - 11/2014
2	Lung Neoplasms (Lung Cancer) 01/2021 - 04/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2020
2	Carcinogenesis 01/2020 - 01/2016
2	Fibrosis (Cirrhosis) 09/2019 - 01/2019
2	Tics (Tic) 01/2019 - 09/2016
2	Myocardial Infarction 07/2018 - 01/2018
2	Polyploidy 01/2017 - 11/2016
2	Esophageal Neoplasms (Esophageal Cancer) 01/2015 - 11/2014
1	Smoldering Multiple Myeloma 01/2021
1	Paraproteinemias (Monoclonal Gammopathy) 01/2021
1	Congenital Bone Marrow Failure Syndromes 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Fanconi Anemia (Fanconi's Anemia) 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2019
1	Gliosis 09/2019
1	Brain Neoplasms (Brain Tumor) 09/2019
1	Halitosis 04/2019
1	Pathologic Complete Response 01/2019
1	Alcoholic Fatty Liver 01/2019
1	Liposarcoma 01/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Synovial Sarcoma (Synovioma) 01/2019
1	Myxoid Liposarcoma 01/2019
1	Residual Neoplasm 01/2019

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2015
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2013
5	Pharmaceutical PreparationsIBA 01/2021 - 01/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2017
3	Cyclin BIBA 01/2021 - 01/2013
3	Antimitotic AgentsIBA 01/2021 - 01/2013
3	Circulating Tumor DNAIBA 11/2020 - 01/2019
3	Cell-Free Nucleic AcidsIBA 01/2020 - 02/2018
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 11/2014
3	Sorafenib (BAY 43-9006)FDA Link 04/2018 - 04/2013
3	RNA (Ribonucleic Acid)IBA 09/2016 - 01/2015
3	AntigensIBA 09/2012 - 03/2006
2	Extracellular Matrix ProteinsIBA 01/2021 - 01/2016
2	Bortezomib (Velcade)FDA Link 01/2021 - 09/2010
2	Anaphase-Promoting Complex-CyclosomeIBA 01/2021 - 12/2013
2	Messenger RNA (mRNA)IBA 01/2021 - 04/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021 - 01/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 05/2012
2	CytokinesIBA 09/2019 - 01/2019
2	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 09/2016
2	Metalloproteases (Metalloproteinases)IBA 01/2019 - 01/2014
2	Cadherins (E-Cadherin)IBA 01/2019 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2014
2	MicroRNAs (MicroRNA)IBA 07/2018 - 01/2018
2	Interleukin-15 (Interleukin 15)IBA 04/2018 - 01/2018
2	AntibodiesIBA 01/2017 - 12/2010
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2021
1	PND 1186IBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	Taxoids (Taxanes)IBA 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	UbiquitinIBA 01/2021
1	Ligases (Synthetase)IBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	ursodoxicoltaurineIBA 01/2021
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	Anaplastic Lymphoma KinaseIBA 12/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2020
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2020
1	Beclin-1IBA 01/2020
1	NucleotidesIBA 01/2020
1	Purinergic P2Y2 ReceptorsIBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 09/2019
1	ChitinasesIBA 09/2019
1	Small Interfering RNA (siRNA)IBA 01/2019

Therapy/Procedure

10	Therapeutics 01/2021 - 09/2010
6	Cell Transplantation 01/2021 - 04/2010
4	Immunotherapy 10/2022 - 03/2006
4	Transplantation 01/2021 - 09/2016
3	Drug Therapy (Chemotherapy) 01/2021 - 09/2016
2	Stem Cell Transplantation 01/2021 - 01/2019
2	Lasers (Laser) 04/2019 - 05/2007
1	Blood Component Removal (Apheresis) 01/2021
1	Radiotherapy 01/2021
1	Chemoprevention 01/2020